Arrowstreet Capital, Limited Partnership Ionis Pharmaceuticals Inc Transaction History

Arrowstreet Capital, Limited Partnership

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $1.3 Million - $1.77 Million	41,104 New	41,104 $1.52 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $1.05 Million - $1.44 Million	-41,100 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $1.74 Million - $2.1 Million	-51,800 Reduced 55.76%	41,100 $1.38 Million
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $3.21 Million - $4.39 Million	92,900 New	92,900 $3.71 Million
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $1.18 Million - $1.57 Million	-26,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $1.23 Million - $1.64 Million	26,000 New	26,000 $1.23 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $588,931 - $897,553	-14,157 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$53.85 - $65.27 $99,245 - $120,292	-1,843 Reduced 11.52%	14,157 $855,000
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $944,960 - $1.15 Million	16,000 New	16,000 $959,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $11.4 Million - $15.9 Million	-184,174 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $9.75 Million - $14.9 Million	184,174 New	184,174 $14.9 Million

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.